CHARACTERIZATION OF RECEPTORS FOR HUMAN RECOMBINANT INTERFERON-γ IN HUMAN CELLS
スポンサーリンク
概要
- 論文の詳細を見る
Highly purified human recombinant interferon-γ (ReIFN-γ) was radioiodinated with ^<125>I-Bolton-Hunter reagent and used to characterize the receptor for ReIFN-γ. ^<125>I ReIFN-γ specifically and saturably bound four human cells tested, FL, WISH, Daudi, and HL-60,which were reported to have ReIFN-γ binding sites. Scatchard analysis of the binding data of FL cells revealed the presence of 5200 binding sites per cell and a K_d value of 2.1×10^<-10>M. Although the binding of ^<125>I ReIFN-γ was inhibited by unlabelled natural IFN-γ and ReIFN-γ, it was not inhibited by unlabelled human ReIFN-α and ReIFN-β, suggesting that receptors for (Re) IFN-γ were different from those for IFN-α or IFN-β. However, ReIFN-γ displaced the binding of ^<125>I ReIFNγ 3 to 5 times more effectively than IFN-γ. Internalization of ^<125>I ReIFN-γ bound to the cell surface receptor was observed at 37℃. Pretreatment of FL cells with unlabeled ReIFN-γ caused a concentration-dependent down-regulation in the ReIFN-γ receptor, which was specific for IFN-γ and reversible. From these studies, we concluded that although the ReIFN-γ is not identical to putative IFN-γ, the recombinant form binds to the same binding sites for IFN-γ and does not bind to the binding sites for IFN-α or β.
- 公益社団法人日本薬学会の論文
著者
-
AKINAGA Shiro
Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd.
-
Akinaga S
Kyowa Hakko Kogyo Co. Ltd. Shizuoka Jpn
-
Akinaga Shiro
Pharmaceutical Research Institute Kyowa Hakko Kogyo Co. Ltd
-
GOMI Katsushige
Pharmaceutical Research Institute, Kyowa Hakko Kogyo Company, Ltd.,
-
Oka T
Pharmaceutical Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
OKA TETSUO
Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
-
MORIMOTO MAKOTO
Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
-
Morimoto M
Pharmaceutical Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Gomi Katsushige
Pharmaceutical Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Gomi Katsushige
Pharmaceutical Research Institute Kyowa Hakko Kogyo Company Ltd.
関連論文
- UCN-01 (7-Hydoxystaurosporine) Inhibits in vivo Growth of Human Cancer Cells through Selective Perturbation of G1 Phase Checkpoint Machinery
- G1-checkpoint Function Including a Cyclin-dependent Kinase 2 Regulatory Pathway as Potential Determinant of 7-Hydroxystaurosporine (UCN-01)-induced Apoptosis and G1-phase Accumulation
- Synthesis and Antitumor Activity of Duocarmycin Derivatives : A-Ring Pyrrole Compounds Bearing 5-Membered Heteroarylacryloyl Groups
- Synthesis and Antitumor Activity of Duocarmycin Derivatives : Modification of Segment A of Duocarmycin B2
- Wagner-Meerwein Rearrangement of Duocarmycins
- Hyperlipemia and Early Pancreatic Injury Induced by Ethanol Intake in Rats
- GEX1 Compounds, Novel Antitumor Antibiotics Related to Herboxidiene, Produced by Streptomyces sp. : II. The Effects on Cell Cycle Progression and Gene Expression
- GEX1 Compounds, Novel Antitumor Antibiotics Related to Herboxidiene, Produced by Streptomyces sp. : I. Taxonomy, Production, Isolation, Physicochemical Properties and Biological Activities
- GE3, a Novel Hexadepsipeptide Antitumor Antibiotic, Produced by Streptomyces sp. I. Taxonomy, Production, Isolation, Physico-chemical Properties, and Biological Activities
- Effect of Nd422 Addition on Jc in Nd123 Melt-Textured Bulk Superconductor
- Pulsed Field Magnetization of Melt-Processed Y-Ba-Cu-O Bulk Superconductor with No Weak Links
- High-Temperature Superconducting Motor Using Y-Ba-Cu-O Bulk Magnets
- A Radicicol Derivative, KF58333, Inhibits Expression of Hypoxia-inducible Factor-1α and Vascular Endothelial Growth Factor, Angiogenesis and Growth of Human Breast Cancer Xenografts
- Metallurgical Reactions and Their Relationships to Enhanced Mechanical Strength in Zr-Bearing YBCO Composite Superconductors
- Mechanical and Superconducting Properties of Ag/YBCO Composite Superconductors Reinforced by the Addition of Zr
- Chrolactomycin, a Novel Antitumor Antibiotic Produced by Streptomyces sp.
- UCS1O25A, a Novel Antibiotic Produced by Acremonium sp.
- CHARACTERIZATION OF RECEPTORS FOR HUMAN RECOMBINANT INTERFERON-γ IN HUMAN CELLS
- ANTITUMOR EFFECT OF HUMAN RECOMBINANT INTERFERON-γ AND -β AGAINST HUMAN OSTEOSARCOMA TRANSPLANTED INTO NUDE MICE
- SYNERGISTIC ANTICELLULAR AND ANTIVIRAL ACTIVITIES OF HUMAN RECOMBINANT INTERFERON-γ AND -β
- CHEMO-IMMUNOTHERAPY OF METHYLCHORANTHRENE-INDUCED FIBROSARCOMA BY CONCANAVALIN A-BOUND TUMOR VACCINE, LEVAMISOLE AND MITOMYCIN C
- ANTITUMOR EFFECT OF HUMAN RECOMBINANT INTERFERON-β AGAINST HUMAN MELANOMAS TRANSPLANTED INTO NUDE MICE